Barely Significant
← all phrases

“may be significant”

13,098 sentences · 13,098 papers · 69,431 search hits before verification

In the literature

7 - 10 Current methods of assessing kidneys rely on donor history and visual inspection, yet even strongly predictive factors signify cohort rather than individual risk, and there may be significant intracohort variability in outcomes. 6 , 9 , 11 - 15 Similarly, the relationship between the macroscopic appearance and transplant outcomes remains ill-defined. 16 , 17 Quality assessment technologies, such as histopathological analysis or machine perfusion, may aid in organ selection by providing an additional, individualized data point.
Studies have also shown increased immunogenicity in STS with the use of RT, however, there may be significant biological heterogeneity with regard to immunogenicity and radiosensitivity between DDLPS and other histologies, and additional prospective data will help elucidate more nuanced pathologic response and survival differences for patients undergoing combination NIT/RT [ 34 , 35 ].
Lapidus Several studies corroborate that first metatarsal shortening may be significant with the Lapidus procedure. 28 , 29 This was dependent on the method used to prepare the tarsometatarsal joint for fusion, with some estimates as high as 7.5 mm with osseous resection and 5.0 mm with curettage. 17 , 30 , 31 To mitigate this, Hatch et al 30 describe the use of a cutting jig to enable precise resection of the first tarsometatarsal joint surfaces, yielding promising results and reducing the mean first metatarsal shortening to 3.1 mm.
This high level of training background means that there may be significant differences in their motor skills, body control, and motor coping abilities, which is crucial for the interpretation of the results of the study of the effects of fatigue and anticipation on their motor performance.
Since the AKR inhibitor 5β-cholanic acid is a well-tolerated naturally occurring bile acid in humans, and since flufenamic acid has been used in clinical trials with manageable toxicities [ 41 ], there may be significant value in conducting clinical trials in which either 5β-cholanic acid or flufenamic acid are co-administered with doxorubicin during chemotherapy.